glp 1 receptor agonists for type 2 diabetes GLP-1 individualized treatment of mellitus New Developments in Pharmacological Treatment
Description
(2020) 17:e1003132
In a recent study published by Nauck et al., all GLP-1 RAs have a common mechanism of action in terms of controlling blood glucose levels, i.e., increased production of insulin during hyperglycemic states, suppressing glucagon secretion, delayed gastric emptying, preventing postprandial glucose spikes, and lowering caloric intake and BMI [3]
Parkinsons disease
This extensive review demonstrates how GLP-1 RAs have transcended traditional therapeutic boundaries by modulating core cellular mechanisms, including mitochondrial enhancement, anti-inflammatory actions, autophagy-mediated quality control, and neuroprotective pathways that underlie multiple disease states
Overgaard RV, Lindberg SO, Thielke D
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Mathiesen DS, Bagger JI, Bergmann NC, Lund A, Christensen MB, Vilsboll T, et al
